Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Redlich

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Journal of Autoimmunity|May 27, 2017
MicroRNA-146a governs fibroblast activation and joint pathology in arthritisVictoria Saferding, Antonia Puchner, Eliana Goncalves-Alves, et al.
Annals of the Rheumatic Diseases|January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trialMichael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Annals of the Rheumatic Diseases|July 1, 2018
Non-classical monocytes as mediators of tissue destruction in arthritisAntonia Puchner, Victoria Saferding, Michael Bonelli, et al.
Annals of the Rheumatic Diseases|June 11, 2013
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task forceJosef S Smolen, Jürgen Braun, Maxime Dougados, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Journal of Autoimmunity|May 27, 2017
MicroRNA-146a governs fibroblast activation and joint pathology in arthritisVictoria Saferding, Antonia Puchner, Eliana Goncalves-Alves, et al.
Annals of the Rheumatic Diseases|January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trialMichael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Annals of the Rheumatic Diseases|July 1, 2018
Non-classical monocytes as mediators of tissue destruction in arthritisAntonia Puchner, Victoria Saferding, Michael Bonelli, et al.
Annals of the Rheumatic Diseases|June 11, 2013
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task forceJosef S Smolen, Jürgen Braun, Maxime Dougados, et al.
Pageof 7